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Abstract
Background: The reduced folate carrier (RFC1) is an integral membrane protein and facilitative anion exchanger that
mediates delivery of 5-methyltetrahydrofolate into mammalian cells. Adequate maternal-fetal transport of folate is
necessary for normal embryogenesis. Targeted inactivation of the murine RFC1 gene results in post-implantation
embryolethality, but daily folic acid supplementation of pregnant dams prolongs survival of homozygous embryos until
mid-gestation. At E10.5 RFC1-/- embryos are developmentally delayed relative to wildtype littermates, have multiple
malformations, including neural tube defects, and die due to failure of chorioallantoic fusion. The mesoderm is sparse and
disorganized, and there is a marked absence of erythrocytes in yolk sac blood islands. The identification of alterations in
gene expression and signaling pathways involved in the observed dysmorphology following inactivation of RFC1-mediated
folate transport are the focus of this investigation.
Results: Affymetrix microarray analysis of the relative gene expression profiles in whole E9.5 RFC1-/- vs. RFC1+/+ embryos
identified 200 known genes that were differentially expressed. Major ontology groups included transcription factors
(13.04%), and genes involved in transport functions (ion, lipid, carbohydrate) (11.37%). Genes that code for receptors,
ligands and interacting proteins in the cubilin-megalin multiligand endocytic receptor complex accounted for 9.36% of the
total, followed closely by several genes involved in hematopoiesis (8.03%). The most highly significant gene network
identified by Ingenuity™ Pathway analysis included 12 genes in the cubilin-megalin multiligand endocytic receptor
complex. Altered expression of these genes was validated by quantitative RT-PCR, and immunohistochemical analysis
demonstrated that megalin protein expression disappeared from the visceral yolk sac of RFC1-/- embryos, while cubilin
protein was widely misexpressed.
Conclusion: Inactivation of RFC1 impacts the expression of several ligands and interacting proteins in the cubilin-
amnionless-megalin complex that are involved in the maternal-fetal transport of folate and other nutrients, lipids and
morphogens such as sonic hedgehog (Shh) and retinoids that play critical roles in normal embryogenesis.
Published: 9 April 2008
BMC Genomics 2008, 9:156 doi:10.1186/1471-2164-9-156
Received: 29 March 2007
Accepted: 9 April 2008
This article is available from: http://www.biomedcentral.com/1471-2164/9/156
© 2008 Gelineau-van Waes et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 17
(page number not for citation purposes)
BMC Genomics 2008, 9:156 http://www.biomedcentral.com/1471-2164/9/156Background
Folate and vitamin B12 are essential vitamins derived
from various food sources that play an important role in
erythropoiesis, DNA biosynthesis, and embryogenesis.
Nutritional deficiencies or genetic variations that impact
folate and/or vitamin B12 homeostasis may result in meg-
aloblastic anemia [1], and failure of maternal-fetal trans-
port of these nutrients has been shown to adversely
impact normal embryogenesis [2-5]. Folate is a vitamin
derived from plant sources that consists of a pteridine ring
structure attached to a para-aminobenzoic acid side chain.
Tetrahydrofolate, the reduced form of folate, functions as
an important co-factor for donating or accepting methyl
groups. Adequate levels of folate for the incorporation of
single carbon groups into purine, or methylation of deox-
yuridylate to form thymidylate, are necessary for DNA
biosynthesis. Vitamin B12, also known as cobalamin, is
another important vitamin that is obtained from dietary
sources such as meat, fish and soybean. Folate and cobala-
min metabolism are highly interdependent. In mammals,
cobalamin functions as a co-enzyme for methionine syn-
thase, which is involved in the tetrahydrofolate-depend-
ent methylation of homocysteine to methionine [6].
According to the "folate-trap hypothesis", cobalamin defi-
ciency results in 'trapping' of tetrahydrofolate, producing
a functional folate deficiency that leads to impaired eryth-
ropoiesis and DNA biosynthesis [7].
The primary mechanisms for folate delivery into the cell
are through (1) carrier-mediated (reduced folate carrier;
RFC1) or (2) receptor-mediated (folate receptor; Folr1)
processes. These two transport systems are distinguished
by their unique patterns of tissue expression, differing
protein structures, specificities for oxidized vs. reduced
folates, and divergent mechanisms for transmembrane
transport of folates [8]. As mammalian cells are not capa-
ble of synthesizing folates de novo, these two transport sys-
tems play a critical role in mediating folate uptake for the
biosynthesis of purines, pyrimidines, and certain amino
acids that are necessary for cell survival and proliferation.
It has recently been discovered that megalin, a large mul-
tiligand endocytic receptor of the low density lipoprotein
receptor family, is capable of binding and mediating
uptake of the soluble form of the GPI-anchored folate
receptor Folr1, providing yet another pathway for the cel-
lular internalization of folate [9].
The principal route of folate transport into mammalian
cells is via the reduced folate carrier (RFC1), a bidirec-
tional transporter characterized by twelve transmembrane
domains [8,10]. RFC1 preferentially transports reduced
folates, such as N5-methyltetrahydrofolate or N5-
formyltetrahydrofolate, which are anionic at physiologi-
cal pH. It functions as a facilitative anion exchanger, capa-
ble of transporting anionic folates into the cell via a co-
transport system in which the uphill transport of folate is
coupled to the downhill efflux of organic phosphates or
sulfates [8,11]. Folate uptake into intestinal cells is mark-
edly increased at pH 5.5 relative to pH 7.4 [12,13], sug-
gesting that RFC1-mediated folate uptake is highly
dependent on acidic extracellular pH. In adult tissues,
RFC1 expression is observed in the brush border of the
small and large intestine, and in the basolateral mem-
brane of renal tubular epithelium, as well as in hepato-
cytes, choroid plexus, and the retinal pigment epithelium
[14]. During development, RFC1 is highly expressed in
multiple tissue types, including the placenta and yolk sac,
neural tube, craniofacial region, limb buds and heart
[14,15].
We have recently characterized the role of RFC1 during
embryonic development in a mouse model in which
RFC1 was inactivated by homologous recombination
[16]. Without maternal folate supplementation, RFC1-/-
embryos die in utero shortly after implantation. RFC1-/-
embryos harvested from dams receiving low doses of sup-
plemental folic acid (25 mg/kg/day SQ), survive to mid-
gestation (E10.5), but are developmentally delayed, and
display multiple malformations, including severe neural
tube defects, craniofacial, heart, and limb abnormalities.
Examination of the placenta reveals that embryolethality
is due to a failure of chorioallantoic fusion. The fetal vas-
culature appears to form normally, but there is a pro-
nounced absence of erythropoiesis, with very few
nucleated fetal red blood cells present in either the fetal
blood vessels or the yolk sac blood islands. Maternal
folate supplementation with 50 mg/kg/day results in sur-
vival to term of 22% of the RFC1 mutants, although the
surviving fetuses present with multiple malformations of
the craniofacies, lungs, heart and skin.
The reduced folate carrier gene has previously been inacti-
vated in a mouse model [17] through targeted disruption
of a large part of exon 3. Zhao [17] reported that the RFC1-
/- embryos died in utero before E9.5, but near-normal
development could be sustained by supplementing preg-
nant RFC+/- dams with daily doses of 1 mg folic acid SQ.
Approximately 10% of the partially rescued RFC1-/- pups
were live-born, but all died within 12 days post-partum.
In the Zhao [17]RFC1 knockout mouse model, perinatal
lethality was attributed to a marked absence of erythro-
poiesis in bone marrow, spleen, and liver. Our recent find-
ings indicate that inactivation of RFC1 results in
congenital malformations of the heart and lungs that
undoubtedly contribute to the failure of RFC1 mutants to
survive postnatally.
The purpose of this report is to identify alterations in bio-
chemical and/or molecular genetic pathways that may
play a role in the abnormal embryonic morphogenesisPage 2 of 17
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study, the gene expression profiles of whole E9.5 RFC1-/-
embryos were compared to that of RFC1+/+ littermates har-
vested from pregnant dams receiving daily low dose (25
mg/kg/day S.Q.) folate supplementation. Our microarray
analysis shows that in the absence of functional RFC1, the
expression profiles of numerous transcription factors, as
well as several genes involved in hematopoiesis, ion
homeostasis, and genes encoding for receptors and/or lig-
ands in the cubilin-megalin multiligand endocytic recep-
tor complex are significantly altered. Follow-up
quantitative RT-PCR validation confirms alterations in the
expression profiles of several ligands and interacting pro-
teins in the cubilin-megalin complex that are involved in
nutrient transport of vitamins and lipids to the develop-
ing embryo.
Results
Microarray analysis
In the microarray analysis of E9.5 RFC1-/- embryos vs.
RFC1+/+ embryos, the expression patterns of 783 genes
were found to be significantly altered at the 0.001 level.
However, when looking at the false discovery rate (FDR),
only 288 genes (probe sets) were significantly altered at
the 0.001 level. Several of the probe sets represent alter-
nate transcripts for the same gene. Taking this into
account, 250 unique genes were identified as differentially
expressed in the microarray analysis. Of these, 200 repre-
sent known genes, while 50 are ESTs or unknowns. The 12
known genes in our data set that have been identified as
cell surface receptors, ligands, or interacting proteins in
the cubilin-megalin multiligand endocytic receptor com-
plex are listed in Table 1, and the complete set of 200
known genes that were differentially expressed following
statistical analysis of the microarray data are also provided
[see Additional file 1]. The genes have been categorized
according to ontology groups, and the file contains the
accession number, gene symbol, gene name, and the
mean fold change for the expression level of each gene.
The fold-change represents the value for the comparison
of level of gene expression in the RFC1-/- embryos relative
to the RFC1+/+ embryos. (The data discussed in this publi-
cation have also been deposited in NCBIs Gene Expres-
sion Omnibus [18] and are accessible to the public
through GEO Series accession number GSE10659).
Distribution of gene ontology groups
A pie chart showing the relative distribution (percentage)
of the gene ontology groups identified in the microarray
analysis of the RFC1-/- vs. RFC1+/+ embryos is shown in
Figure 1. The largest ontology group of known genes that
was altered included several families of transcription fac-
tors (13.04%), followed by genes involved in transport
functions (ion, lipid, carbohydrate) (11.37%). Genes that
code for receptors, ligands and interacting proteins in the
cubilin-megalin multiligand endocytic receptor complex
account for 9.36% of the total, followed closely by several
genes involved in hematopoiesis (8.03%).
Ingenuity Pathway Analysis
The most highly significant gene network identified in the
Ingenuity Pathway analysis (Ingenuity™ Systems, Inc.,
Mountain View, CA) of our Affymetrix microarray data is
shown in Figure 2. Based on new information available in
the recent literature (interactions not yet reported in the
latest release of the Ingenuity Knowledge Base), we iden-
tified an additional 11 genes of interest that were placed
into this network. These additional genes are represented
by 11 custom nodes and edges. In the original "Network
1" of the Ingenuity Pathway Analysis, 32 of the 34 genes
that appear were statistically up or down-regulated on our
microarray analysis, giving it a score of 55. With the addi-
tion of the custom nodes/edges (Folr1, Shh, Timd2, Myo6,
Dab2) and nodes from the Cubn neighborhood–(Tf*,
Table 1: Microarray gene list: Multiligand endocytic receptor complex
RFC1, E 9.5, whole embryo, nullizygote vs wildtype, Affymetrix mouse 430_2 microarray results
RefSeq Transcript ID Gene Symbol Affy Description Fold Change
NM_009692 Apoa1 apolipoprotein A-I 65.97
XM_130038 Cubn cubilin (intrinsic factor-cobalamin receptor) 35.49
NM_018816 Apom apolipoprotein M 23.41
NM_013697 Ttr transthyretin 18.02
NM_011255 Rbp4 retinol binding protein 4, plasma 14.43
NM_134249 Timd2 T-cell immunoglobulin and mucin domain containing 2 12.04
NM_133977 Trf transferrin 9.41
NM_009696 Apoe apolipoprotein E 4.70
NM_001008702///NM_023118 Dab2 disabled homolog 2 (Drosophila) 3.78
NM_008662 Myo6 myosin VI 3.56
NM_017399 Fabp1 fatty acid binding protein 1, liver 3.10
NM_013587 Lrpap1 low density lipoprotein receptor-related protein associated protein 1 2.16Page 3 of 17
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that already appear in the default "Network 1"} 34 of the
46 genes in the custom network were found to be signifi-
cant. Many of the key genes highlighted in this top net-
work are members of the ontology group that includes
receptors, ligands and interacting proteins found in the
cubilin-megalin multiligand endocytic receptor complex.
This complex became the focus of further studies due to its
important role in the uptake of folate and other vitamins,
lipids, and nutrients essential for embryonic develop-
ment.
Cubilin-megalin multiligand endocytic receptor complex
A diagram of the structure of the cubilin-amnionless-meg-
alin multiligand receptor endocytic complex is shown in
Figure 3[19]. Megalin and cubilin are two multifunctional
endocytic receptors that act in concert in certain tissues to
mediate the uptake of a variety of lipoproteins and vita-
min-carrier complexes [19-21]. Striking similarities in
temporal and spatial expression patterns of megalin and
cubilin have been described in mid-late gestation rat
embryos [22], although differential patterns of expression
have also been reported during early embryonic develop-
ment in the mouse [23]. Megalin (Lrp2) is a low-density
lipoprotein receptor-related protein that is co-expressed
Distribution of gene ontology groupsFigure 1
Distribution of gene ontology groups. A pie chart showing the relative distribution (percentage) of the gene ontology 
groups identified in the microarray analysis of E9.5 RFC1-/- vs. RFC1+/+ embryos is shown. A complete list of the genes within 
each of these gene ontology groups that were differentially expressed following statistical analysis of the microarray data is 
provided in [Additional file 1].Page 4 of 17
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Ingenuity™ Pathway gene networkFi ure 2
Ingenuity™ Pathway gene network. The most highly significant gene network identified in the Ingenuity™ Pathway analysis of our Affymetrix microarray data is shown. An 
additional 11 'custom' genes were placed into this network based on new information available in the recent literature. Many of the key genes highlighted in this top network are 
members of the ontology group that includes receptors, ligands and interacting proteins found in the cubilin-megalin multiligand endocytic receptor complex. The networks are 
displayed graphically as nodes (genes/gene products) and edges (the biological relationships between the nodes). The intensity of the node color indicates the degree of up- (red) 
or down- (green) regulation in gene expression in our microarray analysis. Nodes are displayed using various shapes that represent the functional class of the gene product. 
Edges are displayed as a direct interaction (solid line) or as an indirect/unknown interaction (dashed line). The nodes have also been arranged to show the location of the gene/
gene product with respect to cellular or subcellular localization (e.g. plasma membrane, cytoplasm, nucleus, etc.).
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Cubilin-megalin multiligand endocytic receptor complexFigure 3
Cubilin-megalin multiligand endocytic receptor complex. A cartoon diagram of the structure of the cubilin-amnion-
less-megalin multiligand receptor endocytic complex [19] is shown. Megalin is a cell-surface receptor/transporter consisting of 
a large extracellular region, a single transmembrane domain, and a C-terminal cytoplasmic tail. The extracellular domain of 
megalin contains four clusters of lipoprotein receptor ligand-binding repeats (blue), growth factor repeats, an EGF repeat, and 
YWTD spacer regions. The second cluster of ligand-binding repeats has been identified as a common binding site for several 
ligands including apolipoprotein E (Apo E), apolipoprotein M (Apo M), retinol binding protein (Rbp), and transthyretin (Ttr). 
Megalin also binds the soluble form of the folate receptor (Folr1), and the morphogen sonic hedgehog (Shh). The cytoplasmic 
tail of megalin binds Dab2, a cytosolic adapter protein important for megalin-mediated endocytosis, and Dab2 binds and 
recruits Myo6 to clathrin-coated vesicles. The receptor-associated protein (Lrpap1; RAP) binds both megalin and cubilin. Cubi-
lin is a peripheral membrane receptor comprised of a short amino terminal, eight EGF type domains, and 27 CUB domains 
(green). The amino-terminal end of cubilin is attached to the extracellular part of amnionless (Amn), and amnionless provides 
the transmembrane domain necessary for the anchoring and endocytic trafficking of cubilin. Cubilin ligands include transferring 
(Trf), albumin, hemoglobin, apolipoprotein A1 (ApoA1), and intrinsic factor (IF)-vitamin B12.
BMC Genomics 2008, 9:156 http://www.biomedcentral.com/1471-2164/9/156with cubilin in many absorptive epithelia, including the
neuroepithelium and yolk sac of developing embryos.
Several studies indicate a critical role for megalin in nor-
mal embryogenesis [24]. Megalin has been shown to bind
and internalize multiple ligands, including the soluble
folate binding protein (Folr1), and sonic hedgehog (Shh),
among others [19,25-29]. Lack of megalin receptor func-
tion in a knockout mouse model results in abnormalities
of the kidneys, lungs, central nervous system and cranio-
facies, and megalin-deficient pups die perinatally within
the first few minutes of life due to respiratory insufficiency
[30]. Conditional inactivation of megalin in the neuroep-
ithelium has been shown to result in a loss of Shh expres-
sion in the ventral telencephalon [31], indicating that
megalin-mediated uptake of Shh in the neuroepithelium
is critical for early forebrain development [32].
Cubilin (gp280) functions as an endocytic receptor for the
intrinsic factor-cobalamin complex in the intestine, and as
a receptor for apolipoprotein A1 and albumin reabsorp-
tion in the kidney proximal tubules and visceral yolk sac
[33]. Cubilin is a peripheral membrane receptor com-
prised of a short amino terminal amphipathic helix, eight
EGF type domains, and 27 amino acid modules known as
CUB domains [34]. Although cubilin lacks a classic trans-
membrane domain and cytoplasmic tail, the amino-ter-
minal end is necessary for membrane anchoring [35]. The
amino-terminal region of cubilin is attached to the extra-
cellular part of amnionless, which provides the transmem-
brane domain necessary for anchoring and endocytic
trafficking of cubilin [36]. Antibodies directed against
cubilin have been reported to have teratogenic effects in
rats [37], and targeted disruption of cubilin in a mouse
model reveals an essential role for this receptor in embry-
ogenesis [38]. Homozygous inactivation of the murine
cubilin gene results in embryolethality between E7.5 –
E13.5. Cubilin knockout mice are characterized by defects
in certain mesodermally-derived tissues, including failure
of somite formation and abnormalities of the yolk sac
blood islands and visceral endoderm [38].
A comparative overview of the developmental phenotype
of mice with genetically engineered deletions in critical
components of the cubilin-megalin multiligand endocytic
receptor complex including Cubilin, Amnionless, Megalin,
Receptor-Associated Protein (RAP; Lrpap1), and Disabled
homolog-2 is provided [see Additional file 2]. The pheno-
types of these mutants are compared to the developmen-
tal anomalies observed following genetically engineered
deletions in the folate transporters Folr1 and RFC1. RFC1-
/- embryos on low dose maternal folate supplementation
(such as those examined in the microarray analysis) dis-
play certain phenotypic traits in common with the more
severely affected cubilin, amnionless, and Dab2 knockouts,
including failure of chorioallantoic fusion and defects in
mesoderm-derived structures, whereas RFC1-/- embryos
that survive to term following high dose maternal folate
supplementation display a range of malformations more
similar to the megalin knockout mutants.
Quantitative real-time PCR validation
Genes in the cubilin-megalin multiligand endocytic
receptor complex identified in the Affymetrix microarray
analysis, Ingenuity Pathway analysis, or through addi-
tional information available in the literature were selected
for further expression analysis by quantitative RT-PCR
(qRT-PCR). The twelve genes selected for qRT-PCR valida-
tion of alterations in gene expression are listed along with
a description of their function, and the ABI primer/probe
sets used for these experiments [see Additional file 3]. Fig-
ure 4 and Table 2 list the results of the qRT-PCR analysis,
including p-values, and a graph of the relative levels of
expression of the selected genes in the multiligand recep-
tor endocytic complex is shown. Cubn, ApoA1, Amn, Trf,
Timd2, Rbp4, Ttr, and the GPI-anchored folate receptor
(Folr1) are significantly upregulated in E9.5 RFC1-/-
embryos relative to E9.5 RFC1+/+ littermates (*p < .05; **p
< .01). However, the qRT-PCR analysis did not detect sta-
tistically significant changes in the expression of Lrp2,
Lrpap1, Dab2, or Shh. Error bars represent SEM values.
Although neither Folr1 nor megalin gene expression made
the cut-off for statistical significance on our microarray
analysis, we included them in our qRT-PCR analysis
because of their presence in the multiligand endocytic
receptor complex, and their important role in nutrient
delivery to the developing embryo (Folr1 was upregulated
5.3 fold, p < .0003 on the microarray analysis, but did not
make the cut-off for the FDR level). qRT-PCR results dem-
onstrated no significant difference in message levels of
megalin between the two groups, but a 10-fold increase in
Folr1 expression was detected (p < .017) in RFC1-/-rela-
tive to RFC+/+ littermates. RT-PCR validation also dem-
onstrates a highly significant upregulation of
cubilinmessage in RFC1-/- embryos (77-fold, p < .002).
Amn mediates cell-surface localization and endocytic
function of cubilin in the visceral endoderm [39]. Amn
did not make the list of 288 genes identified as statistically
significant in our microarray analysis using the stringent
cut-off of 0.001 for adjusted p-values (p = .00109). How-
ever, due to its critical role in cubilin expression and func-
tion, we chose to further analyze amnionless gene
expression levels by quantitative RT-PCR. Our results
show that, similar to cubilin, the expression of amnion-
less was highly significantly upregulated (75-fold; p <
.002) in RFC1-/- embryos.
Immunohistochemistry
During normal embryonic development, megalin and
cubilin are highly expressed in the visceral endoderm (VE)Page 7 of 17
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BMC Genomics 2008, 9:156 http://www.biomedcentral.com/1471-2164/9/156and visceral yolk sac (VYS), and function cooperatively in
the maternal-fetal transfer of multiple nutrients and mor-
phogens. The VE is a polarized epithelial tissue that sur-
rounds the developing epiblast. The apical surface of the
VE faces maternal tissues, and contains numerous micro-
villi that function to absorb nutrients from the maternal
environment [40]. Additional roles in patterning anterior-
posterior polarity of the early embryo, correct positioning
of the primitive streak, induction of blood precursors, and
forebrain development have been ascribed to the anterior
VE [41-43]. Following implantation, the VE surrounding
the epiblast differentiates to form the VYS. The VYS con-
tinues to play a critical role in maternal-fetal nutrient and
waste exchange prior to establishment of the chorioallan-
toic placenta [44].
Immunohistochemical expression of cubilin, megalin
and Folr1 protein in E9.5 RFC1+/+ and RFC1-/- embryos
and extra-embryonic membranes was examined. Expres-
sion of cubilin, megalin and Folr1 protein in the visceral
yolk sac (VYS) is shown in Figure 5. Cubilin (5A), megalin
(5C) and Folr1 (5E) protein are all highly expressed on
the apical side of the VYS in E9.5 RFC1+/+ embryos (brown
staining). Cubilin is also highly expressed on the apical
side of the VYS in E9.5 RFC1-/- embryos (5B). Megalin
expression, however, is completely absent from the VYS of
RFC1 mutants (5D). Folr1 protein expression is absent
Quantitative RT-PCR relative gene expression levelsFigure 4
Quantitative RT-PCR relative gene expression levels. The results of the quantitative RT-PCR validation experiments 
are shown in the graph. Genes were selected for the RT-PCR analysis based on the results of the microarray analysis, or 
because of their presence in the cubilin-megalin multiligand endocytic receptor complex. The red bars on the left represent the 
fold change in the expression of cubilin and cubilin-related genes and the blue bars on the right represent the fold change in the 
expression of megalin and megalin-related genes relative to the expression of the housekeeping genes Ppil2 and Dctn6. (*p < 
.05; **p < .01) Error bars represent SEM values. Gene symbols, relative expression levels and p values are provided in the cor-
responding Table 2. Cubilin (Cubn), Apolipoprotein A1 (ApoA1), Amnionless (Amn), Transferrin (Trf), T-cell immunoglobin and mucin 
domain containing 2 (Timd2), Megalin (Lrp2), Lipoprotein receptor-associated protein 1 (Lrpap1), Disabled (Dab2), Folate Receptor 
(Folr1), Retinol Binding Protein 4 (Rbp4), Sonic Hedgehog (Shh), Transthyretin (Ttr).
Table 2: qRT-PCR Gene Expression Levels
Gene Relative Expression P value
Cubn 76.6 0.002
ApoA1 106.4 0.001
Amn 75.3 0.002
Trf 24.6 0.005
Timd2 32.7 0.003
Lrp2 1.9 0.462
Lrpap1 2.3 0.279
Dab2 5.1 0.051
Folr1 10.0 0.017
Rbp4 24.8 0.004
Shh 1.8 0.496
Ttr 29.8 0.004
Ppil2 1.1 1.000
Dctn6 0.9 0.998Page 8 of 17
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BMC Genomics 2008, 9:156 http://www.biomedcentral.com/1471-2164/9/156from the apical plasma membrane of the VYS in RFC1-/-
embryos, but demonstrates increased expression in the
endothelial cell layer of the yolk sac blood islands (5F).
Expression of cubilin and megalin protein in the neuroep-
ithelium is shown in Figure 6. Megalin expression is
observed in the retinal pigment epithelium, cells lining
the otic vesicle, and exclusively on the apical side of neu-
roepithelial cells (6A; red arrows) in E9.5 RFC1+/+
embryos (brown staining). In RFC1-/- embryos, however,
megalin is expressed on both the apical (6B; red arrows)
and basolateral side (6B; purple arrowheads) of the neu-
roepithelium. Positive staining for megalin is also
observed in the surface ectoderm, notochord, pericar-
dium, and endothelial cells lining vascular structures (pri-
mary head veins/cardinal veins and vitelline vein) of
RFC1+/+ embryos, but megalin staining is faint or absent
in the (hindbrain) notochord and endothelium of similar
vascular structures in RFC1 mutant embryos (not shown).
Similar to megalin, cubilin expression is observed in the
surface ectoderm (6C; black arrows), retinal pigment epi-
thelium, otic vesicle, and apical side of neuroepithelial
cells (6C; 6E; red arrows) in E9.5 RFC1+/+embryos. In
RFC1-/- embryos, however, cubilin is misexpressed on the
basolateral side of neuroepithelial cells (6D; 6G; purple
arrowheads), Discrete, positive staining for cubilin is
observed in the notochord of RFC1+/+ embryos (6F, yel-
low arrow). In contrast, the expression of cubilin protein
appears to be highly upregulated and widespread
throughout the (sparse) mesenchyme underlying the neu-
ral tube (NT) of RFC1-/- embryos, especially in the region
surrounding the notochord (6D, 6H, yellow arrow). Cubi-
lin staining is present in the pericardium of both RFC1
wildtype (6I; black arrowhead) and mutant embryos.
Although there are a few cells that stain positive for cubi-
lin in the trabeculae of the common ventricular chamber
in the RFC1 wildtype heart, cubilin expression is dramati-
cally upregulated throughout the myocardium of the
developing heart in RFC1 mutants (6J).
Discussion
In the present study, microarray analysis of gene expres-
sion in whole E9.5 RFC1-/- embryos vs. RFC1+/+ littermates
was utilized as a tool for discovering genetic pathways dis-
rupted in the absence of RFC1 that may play a role in the
observed developmental anomalies. Our results indicate
Cubilin, megalin and Folr1 protein expression in VYSFigure 5
Cubilin, megalin and Folr1 protein expression in VYS. Expression of cubilin, megalin and Folr1 protein in the visceral 
yolk sac is shown in Figure 5. Cubilin (A), megalin (C) and Folr1 (E) protein are all highly expressed on the apical side of the 
visceral yolk sac in E9.5 RFC1+/+ embryos. Cubilin is also highly expressed on the apical side of the visceral yolk sac in E9.5 RFC1-
/- embryos (B). Megalin expression, however, is completely absent from the visceral yolk sac of RFC1 mutants (D). Folr1 pro-
tein expression is absent from the apical plasma membrane of the VYS, but demonstrates increased expression in the endothe-
lial cell layer of the yolk sac blood islands (F).Page 9 of 17
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Cubilin and megalin protein expression in E9.5 embryosFigure 6
Cubilin and megalin protein expression in E9.5 embryos. Immunohistochemical staining was performed on transverse sections through E9.5 RFC1+/+ and RFC1-/- embryos 
in order to examine the relative expression and distribution of megalin and cubilin protein. The level and plane of the sections shown in Figure 6 is illustrated by the line drawn 
through the embryo shown in the upper left hand corner. The red boxes drawn over the neuroepithelium of embryos shown in 6C and 6D (4× magnification) indicate the ori-
entation of the higher magnification panels (40× magnification) shown in 6A, 6B, 6E, and 6G; the apical surface (ventricular side) of the neuroepithelial cells is shown on the 
right of these panels, and the basolateral, or mesenchymal side of the neuroepithelial cells is shown on the left side of the panels. Megalin is expressed exclusively on the apical 
side of neuroepithelial cells in RFC1 wildtype embryos (6A; red arrows), but is expressed on both the apical (6B; red arrows) and the basolateral side (6B; purple arrowheads) 
of the neuroepithelium in RFC1 mutants. Cubilin expression is also restricted to the apical side of neuroepithelial cells in RFC1 wildtype embryos (6C, 6E; red arrows), but is 
misexpressed on the basolateral side of the neuroepithelium in RFC1 nullizygous embryos (6D, 6G; purple arrowheads). Staining for cubilin protein is visible in the surface ecto-
derm of RFC1+/+ embryos (6C; black arrows), and discrete staining is also observed in the notochord (6C, 6F; yellow arrow). Cubilin expression is highly upregulated in the cra-
nial mesenchyme of RFC1-/- embryos (shown in panel 6D) relative to wildtype littermates, especially in the region surrounding the notochord (6H; yellow arrow). Staining for 
cubilin protein is visible in the mesothelial cells of the pericardium of RFC1 wildtype (6I; black arrowhead) and RFC1 mutant embryos (not visible in section shown in 6J), and 
although there are a few cells that stain positive for cubilin in the trabeculae of the common ventricular chamber in the wildtype embryo, cubilin expression is dramatically upreg-
ulated throughout the myocardium of the RFC1 mutant (6J). Normal morphology of the primary head vein/cephalic extension of the anterior cardinal vein (**) and the third 
branchial arch artery (*) in the RFC1 wildtype embryo are shown in (6C); comparable structures labeled in the RFC1 mutant (6D) indicate abnormal vascular morphology. LV: 
left ventricle.
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several genes that code for receptors, ligands, interacting
proteins, and modifiers of the cubilin-megalin multilig-
and endocytic receptor complex. Cubilin and megalin are
both expressed in the VYS and play a critical role in the
maternal-fetal transport of multiple ligands. In the VYS,
blood vessels develop adjacent to the VE cell layer, and
cell-cell interactions between yolk sac mesenchyme and
VE appear to be important for vascular development
[45,46]. Cubilin and megalin are cell surface proteins
expressed in the extraembryonic VE that work coopera-
tively to mediate endocytosis of lipoproteins and vitamin
complexes (including folate and intrinsic factor-vitamin
B12) necessary for erythropoiesis and embryonic develop-
ment. Uptake of folate and nutrients by the VE may there-
fore play a role in development of the adjacent yolk sac
mesenchyme necessary for formation of the allantois and
the initiation of erythropoiesis. In the absence of RFC1,
the primary route of folate uptake into cells may be the
GPI-anchored folate receptor, or internalization of folate
bound to the soluble form of the folate receptor via endo-
cytosis by megalin [28].
Although our RT-PCR results demonstrated no significant
difference in message levels of megalin, a 10-fold increase
in Folr1 expression was detected in RFC1-/- relative to
RFC+/+ littermates. IHC examination of megalin and Folr1
protein expression in RFC1-/- embryos indicates the disap-
pearance of megalin on the apical cell surface of the VYS,
as well as aberrant expression of Folr1, suggesting that, in
addition to the absence of RFC1-mediated folate trans-
port, folate uptake via the Folr1-megalin transport path-
way may also be compromised in the VYS of RFC1-/-
embryos.
Microarray analysis and RT-PCR validation demonstrated
highly significant upregulation of cubilinmessage in E9.5
RFC1-/- embryos. Follow-up IHC analysis suggested a cor-
responding upregulation in cubilin protein, although
technical challenges associated with extracting sufficient
amounts of protein from the tiny E9.5 mutant embryos
precluded western blot quantification. In RFC1+/+, cubilin
protein is observed on the apical surface of neuroepithe-
lial cells, while in mutant embryos, cubilin protein is
observed predominantly on the basolateral side of the
neuroepithelium. Increased expression of cubilin protein
is also widely visible throughout the heart and cranial
mesenchyme in RFC1-/- embryos, and is particularly evi-
dent in the region surrounding the notochord. It is of
interest to note that staining for cubilin remains high on
the apical plasma membrane of the VYS in RFC1 mutants,
and the polarity of expression does not seem to be altered
as it does in the neuroepithelium.
Previous reports suggest that cubilin-mediated endocyto-
sis requires the presence of megalin [47]. If this is the case,
even though cubilin is highly expressed in the VYS of
RFC1-/- embryos, cubilin-mediated internalization of
nutrients in the VYS may be impaired in the absence of
megalin, resulting in the observed accumulation of cubi-
lin on the apical surface of the plasma membrane. Defec-
tive endocytosis of the cubilin-megalin complex and the
observed upregulation in gene expression of transferrin,
transthyretin, retinol binding protein, and several of the
apolipoproteins in RFC1-/- embryos may reflect a compen-
satory upregulation in genes encoding for these cubilin-
megalin transported ligands, secondary to a perceived
deficiency in these nutrients by the developing embryo.
The expression of amn was also significantly upregulated
in RFC1-/- embryos.Amn is expressed in the VE, and forms
a tight complex with the N-terminal end of cubilin, pro-
viding the transmembrane domain necessary for mem-
brane anchoring and endocytic trafficking of cubilin. Amn
is therefore an essential component of the cubilin receptor
complex, facilitating the endocytosis/transcytosis of cubi-
lin-bound ligands and nutrients that are absorbed from
the maternal environment and transported to the devel-
oping embryo during gastrulation. Similar to the RFC1-/-,
embryonic development is arrested during gastrulation in
amn mouse mutants [48-50]. Amn knockout embryos
appear abnormal during the early primitive streak stage
(E6.5–7.0), and then die between E9.5–E10.5. Mutant
embryos are smaller than wildtype littermates, and the
embryonic ectoderm is underdeveloped [48]. Depending
on the genetic background of the amn mouse mutant, the
amniotic membrane may be present [49] or absent [48].
Extra-embryonic structures derived from proximal streak
mesoderm (chorion, allantois, yolk sac blood islands),
and distal streak mesoderm (notochord, foregut, cardiac
mesoderm) in amn mutants appear to develop normally,
but embryos have impaired assembly of derivatives of the
middle primitive streak, resulting in the absence of parax-
ial, intermediate and lateral plate mesoderm.
Dab2
gene expression was upregulated in our microarray analy-
sis of RFC1-/- embryos, but the difference was not statisti-
cally significant on RT-PCR analysis. Dab2 is a cytosolic
adapter protein expressed in the VE and VYS. Inactivation
of murine Dab2 results in disorganization of the VE layer,
and early embryonic lethality prior to gastrulation [51].
Embryos appear to develop normally when Dab2 is con-
ditionally deleted from only the embryo, indicating that
Dab2 expression in the VE is the essential component for
progression of normal embryogenesis [52]. Dab2 binds to
a common sequence in the cytoplasmic tails of lipopro-
tein receptors [53], and has been found in complexes with
megalin in the kidney [54,55], suggesting it may bePage 11 of 17
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endocytosis of megalin. The Dab2 gene is alternatively
spliced to produce two protein products [56]; expression
of the p96 isoform is essential for normal embryonic
development and endocytosis of megalin in the VE
[57,58]. In p96 Dab2 mutants, megalin and cubilin accu-
mulate at the apical plasma membrane surface, and little
intracellular protein or co-localization with early endo-
some markers is observed. However, if the p67 isoform of
Dab2 is inactivated, approximately 50% of homozygotes
die by E10.5, and surviving mutants are small and devel-
opmentally delayed relative to wildtype littermates [58].
Altered expression of Myo6 was also detected in our
microarray analysis of RFC1-/- embryos. Both isoforms of
Dab2 bind and recruit Myo6 to clathrin-coated vesicles
[52,59], and function in clathrin-mediated endocytosis in
polarized epithelial cells [60-62].
Receptor-associated protein (RAP or Lrpap1)
is another component of the cubilin-megalin multiligand
endocytic receptor complex that demonstrated increased
expression in RFC1-/- embryos on our microarray analysis,
but did not show a statistically significant difference in the
RT-PCR analysis. RAP binds both megalin [63] and cubi-
lin [35], and functions as a chaperone-like protein to pro-
mote proper folding and protect the ligand binding sites
of newly processed low density lipoprotein receptor fam-
ily proteins, preventing premature interaction of ligands
with the receptors [64,65]. Megalin binds to two separate
sites on RAP [66] with high affinity, and the binding is cal-
cium-dependent. RAP resides predominantly in the endo-
plasmic reticulum where it binds and escorts megalin
receptors to the golgi. Dissociation of the complex occurs
in late endosomes, triggered by the acidic pH of this com-
partment, and the subsequent protonation of exposed
histidine residues on the surface of RAP that modulate the
binding/release of RAP from megalin [67]. RAP is subse-
quently delivered to lysosomes and degraded, while meg-
alin is recycled to the cell surface [68]. RAP deficiency is
associated with a decrease in megalin expression and a
change in subcellular distribution, causing an accumula-
tion of megalin in intracellular compartments.
Homozygous RAP-deficient mice are viable and appear
phenotypically normal, although megalin expression in
the liver and brain is significantly reduced [69].
In the renal brush border, megalin has been shown to spe-
cifically bind NHE3 [70], a Na+/H+ ion exchanger that
mediates the electroneutral exchange of intracellular H+
for extracellular Na+ across plasma membranes. NHE3
plays a critical role in NaCl homeostasis, and the mainte-
nance of intracellular pH, and has also been shown to
play a role in clathrin-mediated endocytosis and endo-
somal acidification [71]. In renal proximal tubule cells,
NHE3 deficiency or inhibition reduces the relative cell
surface expression of megalin, suggesting intracellular
retention of megalin due to impaired trafficking/recycling
of endosomes back to the plasma membrane [71]. On our
microarray analysis, the gene expression profile of numer-
ous ion channels was altered in RFC1-/-embryos (see sup-
plemental data). RFC1 functions not only in the cellular
uptake of folate, but also as a facilitative anion exchanger,
and its deletion may impact intracellular pH homeostasis.
The association of RAP with megalin is highly pH depend-
ent. Premature dissociation of the RAP-megalin complex
could result in misfolding, or early intracellular degrada-
tion of megalin along the secretory pathway, which might
provide an alternative explanation for the disappearance
of megalin protein on the surface of the VYS and neuroep-
ithelium in RFC1 mutants. The absence of cell surface
expression of megalin would impact uptake of megalin
binding ligands such as transthyretin, hemoglobin, reti-
nol binding protein, apolipoproteins, and shh, and might
also impact megalin-dependent endocytosis of the cubi-
lin-binding ligands such as albumin, transferrin, and
apolipoprotein A-I. This would result in not only in a
folate deficiency, but would also significantly impact
maternal-fetal delivery of numerous other nutrients and
morphogens required for normal vasculogenesis, hemat-
opoiesis and embryonic development.
Conclusion
RFC1 functions as a facilitative anion exchanger and the
primary transporter of reduced folates in multiple tissue
types. Polymorphisms in folate transport genes have been
implicated as risk factors for certain types of birth defects,
and recent evidence from human epidemiological studies
demonstrates an association between polymorphisms in
RFC1 and increased risk for neural tube defects [72-74],
and conotruncal heart defects [75,76]. However, the
mechanism(s) by which altered RFC1-mediated folate
transport perturb normal morphogenesis are currently
unknown. In our knockout mouse model, loss of func-
tional RFC1 during embryogenesis alters the gene expres-
sion of numerous transcription factors and ion channels,
as well as the expression of a group of genes that code for
receptors, ligands and interacting proteins in the cubilin-
megalin multiligand endocytic receptor complex. Altera-
tions in the quantity and location of cubilin and megalin
protein expression are observed in the yolk sac, neuroepi-
thelium, and mesoderm of E9.5 RFC1 nullizygous
mutants. Inactivation of cubilin, amnionless, or dab2
impacts early development, resulting in disorganization
of the visceral endoderm, as well as deficiencies in the for-
mation of mesodermal structures, including the chorioal-
lantois, blood islands, and primitive erythrocytes, similar
to the phenotype observed in RFC1-/- mutants on low dose
maternal folate [see Additional file 2]. Inactivation of lrp2
(megalin) results in multiple malformations later in
embryonic/fetal development that include neuroepithe-Page 12 of 17
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similar to those observed in RFC1-/- mutants on high dose
maternal folate [see Additional file 2]. The spectrum of
malformations observed in RFC1 knockout embryos may
therefore be causally related to altered expression of the
cubilin-amnionless-megalin complex which mediates the
maternal-fetal transport of folate and other nutrients, lip-
ids, and morphogens such as sonic hedgehog (Shh) and
retinoids that play critical roles in normal embryogenesis.
Methods
Experimental animals
RFC1 knockout mice were generated by targeted inactiva-
tion of the RFC1 (Slc19a1) allele as previously described
[77]. Following identification of germline chimeras, the
mutation was transferred from the hybrid stock genetic
background (C57BL/6J) onto an inbred SWV genetic
background. RFC/SWV heterozygous mice were housed in
microisolator cages, maintained on a 12-hour light/dark
cycle, and allowed access to normal Harlan-Teklad (Mad-
ison, WI) rodent chow [#8604] and autoclaved water in
the AAALAC-accredited University of Nebraska Medical
Center (UNMC) laboratory animal facility. All animal
procedures were done in accordance with the Public
Health Service (PHS) policy on Humane Care and Use of
Laboratory Animals, and approved by the UNMC Institu-
tional Animal Care and Use committee. Virgin females
50–70 days of age were mated to males between the hours
of 5–10 PM each evening. Females exhibiting vaginal
plugs at the end of this period were weighed and housed,
up to 5 females per cage, and subsequently placed in treat-
ment groups. The time of conception was considered to be
10 PM on the evening of the mating.
Folate supplementation
Folic acid was purchased from Sigma Chemical Co. (St.
Louis, MO), and dissolved in nanopure water to make a
solution of the desired concentration. Pregnant dams
received folic acid (25 mg/kg) by subcutaneous (S.Q.)
injection (0.1 ml/10 gm bwt), beginning on E0.5, and
continuing daily throughout gestation until the time of
sacrifice.
Fetal collection and morphological staging
At the desired gestational timepoint (E9.5), pregnant
RFC1+/- dams were killed by cervical dislocation, the abdo-
men opened, and the uterine contents removed. The loca-
tion of all viable fetuses and resorption sites were
recorded. Embryos/fetuses were dissected free of the
decidual capsule, including its chorion and amnion, and
examined for the presence of gross abnormalities. Extrae-
mbryonic membranes were collected for genotyping.
Whole fetuses were viewed under a Nikon SMZ 1500 ster-
eomicroscope, and photographed using an Optronics®
(Goleta, CA) camera.
Tissue preparation
Three separate litters were collected, and one RFC1+/+ and
one RFC1-/- embryo from each litter were selected for the
microarray experiment. Pregnant dams were sacrificed,
and E9.5 RFC1 embryos were quickly removed from the
uterus, placed in RNase-free PBS on ice, weighed, snap fro-
zen and stored at -80°C until RNA extraction was per-
formed. Extraembryonic membranes were collected for
genotyping. Following confirmation of genotype, total
RNA was extracted from the embryonic tissue, and pro-
vided to the UNMC microarray core facility for further
processing.
RNA isolation
Total RNA from each whole E9.5 embryo was isolated
using the Arcturus (Mountain View, CA) PicoPure kit with
an on-column DNAse treatment following a 30 second
homogenization using a Kontes Pellet Pestle. Yields of
1.7–39.6 μg of total RNA were obtained, quantitated, and
checked on a NanoChip using a 2100 Bioanalyzer (Agi-
lent Technologies, Palo Alto, CA) in order to determine
sample integrity prior to microarray analysis or QRT-PCR.
All RNAs were stored at -80°C until downstream analysis
was performed. For the microarray experiment, total RNA
was reverse-transcribed, and biotin-labeled cRNA probe
generated.
Microarray experiment
100 ng of total RNA was reverse-transcribed and cRNA
generated per Affymetrix instructions using the Affymetrix
2-cycle Target Labeling Kit. Resultant cRNA probes were
hybridized to the Affymetrix (Santa Clara, CA) Mouse 430
2.0 genome chip, which profiles the expression of 45,101
unique transcripts. Following washing and staining, the
chips were scanned using a GeneChip Scanner 3,000 6 G
in the UNMC microarray core facility. Images were ana-
lyzed using GCOS imaging software. Quality metric
parameters including noise level, background, and the
efficiency of reverse transcription were ascertained for all
hybridizations. Data sets passing the stringent quality rec-
ommendations were normalized using the GCOS soft-
ware, and the raw intensity values exported for further
analysis.
Statistical analysis
Microarray data processing
Analyses were conducted with BRB ArrayTools developed
by Dr. Richard Simon and Amy Peng. Low-level analysis
which converts probe level data to a gene level expression
data was done using robust multiarray average (RMA),
implemented using the rma function of the Affymetrix
package of the Bioconductor project in the R program-
ming language [78-80]. The RMA background correction
method corrects the perfect match (PM) probe intensities
by using a model based on the assumption that thePage 13 of 17
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Quantile normalization was used to normalize the PM
probes and the calculation of summary expression meas-
ures was done using the median polish method, which fits
a multichip linear model to the data, and gives the expres-
sion on the log2 scale. Prior to statistical analysis a filter
was applied to reduce the number of genes examined. A
gene was excluded unless at least 1 out of the 6 arrays had
expression data with a 1.5-fold change or greater in either
direction from the gene's median value. This filter reduced
the number of transcripts examined to 2982.
Differential expression
The mice were paired as litter-mates (one wildtype and
one nullizygous embryo from each litter) and for each
gene, a random-variance paired t-test was conducted to
determine if there was a significant difference in expres-
sion between the mutant and wild type groups for that
gene [81]. P-value adjustment for multiple comparisons
was done with the false discovery rate (FDR) method of
Benjamini-Hochberg [82]. A significance level of 0.001
for the adjusted univariate test was used to select differen-
tially expressed genes. This reduced the number of probe
sets examined to 288.
Quantitative real-time PCR (qRT-PCR) validation
First-strand cDNA synthesis
The SuperScript™ III First-strand Synthesis System for RT-
PCR (Invitrogen, Carlsbad, CA) was used to synthesize
first-strand cDNA from total RNA. cDNAs were synthe-
sized starting with 300 ng of sample RNAs or 1000 ng of
Mouse Universal RNA (MUR, Stratagene, La Jolla, CA)
using oligo(dT) primer according to kit directions. cDNAs
were stored at -20°C. Prior to QRTPCR all cDNAs were
diluted with nuclease-free water to 10 ng/ul (based on the
amount of input RNA).
Quantitative RT-PCR
Quantitative RT-PCR was performed using the Stratagene
MX3000P with MxPro v 3.00 software for Comparative
Quantitation (Stratagene, La Jolla, CA). The 20 μl reaction
consisted of 10 μl 2X TaqMan Universal Master Mix with
AmpErase UNG (Applied Biosystems, Foster City, CA), 1
μl of 20X Target Mix [mouse gene-specific primers (for-
ward and reverse), 900 nM final concentration; mouse
gene-specific 6-FAM-labeled TaqMan MGB probe at 250
nM final concentration] (Applied Biosystems, Foster City,
CA), 1 μl of cDNA, 8 μl nuclease-free water (Ambion, Aus-
tin, TX). Controls included no-template controls and
"Minus reverse transcriptase" controls. All samples were
run in triplicate. Two target genes were used for data nor-
malization: Dctn6 (Dynactin 6) and PPIL2 (peptidylpro-
lyl (cyclophilin)-like isomerase 2). See [Additional file 3]
for Genes of Interest (GOI) used in the experiments. A cal-
ibrator template, Mouse Universal RNA (from mouse tis-
sues, Stratagene, La Jolla, CA) was also used throughout
the course of the assays.
Statistical analysis of quantitative RT-PCR data
Amplification efficiency curves were generated for each
primer/probe set and for each round of cDNA synthesis
using 4-fold serial dilutions of mouse universal RNA
(Stratagene, La Jolla, CA). Ct values were determined
using the MxPro software (Stratagene, La Jolla, CA). Rela-
tive levels of mRNA expression in RFC1 nullizygous and
wildtype embryos were calculated using the Relative
Expression Software Tool (REST v1.9.12) [83]. This soft-
ware provides proper error propagation and robust statis-
tical analysis by using a random reallocation algorithm
with 50,000 iterations. Normalization for each experi-
mental sample used the geometric means of the relative
concentration of each normalizer gene (Dctn6 and PPIL
2) [84].
Ingenuity™ Pathway Analysis
The list of significantly altered genes identified in the
microarray analysis was also examined for the presence of
interacting gene networks using Ingenuity™ Pathway
Analysis software. A data set containing gene identifiers
and their corresponding expression values was uploaded
as an Excel spreadsheet using the template provided in the
application. Each gene identifier was mapped to its corre-
sponding gene object in the Ingenuity Pathways Knowl-
edge Base. For our data set, the Affymetrix probe set ID
was used as an identifier, and an expression value cutoff
of 1.5 was set to identify genes whose expression was sig-
nificantly differentially regulated. These genes were then
used as the starting point for generating biological net-
works. Biological functions were assigned to each gene
network by using the findings that have been extracted
from the scientific literature and stored in the Ingenuity
Pathways Knowledge Base. The biological functions
assigned to each network are ranked according to the sig-
nificance of that biological function to the network. A
Fischer's exact test was used to calculate a p-value deter-
mining the probability that the biological function
assigned to that network is explained by chance alone.
Immunohistochemistry
The distribution and abundance of cubilin and megalin
were characterized immunohistochemically in placentas
and embryos collected from control and folic-acid treated
dams. Pregnant females were euthanized on E9.5,
embryos collected, fixed in fresh 4% paraformaldehyde,
paraffin-embedded, and sectioned at 10 μm. Primary anti-
bodies to cubilin and megalin, and FOLR1 were pur-
chased from Santa Cruz Inc., (Santa Cruz, CA). Primary
antibody dilutions were optimized at cubilin (1:100),
megalin (1:200), and FOLR1 (1:300). Sections were incu-
bated with biotin-conjugated secondary antibody (lightPage 14 of 17
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HRP, and diaminobenzidine (DAB) solution until brown
staining was visible, and counterstained with methyl
green. Sections were viewed under a Nikon Eclipse E800
microscope, photographed using an Optronics® (Goleta,
CA) camera and AnalySIS® (Soft Imaging Systems Corp.,
Lakewood, CA) software, and images processed in Adobe
Photoshop.
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